Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
Andrew G Renehan a Department of Surgery, Christie Hospital NHS
Trust, Manchester M20 4BX, b MRC Health Services
Research Collaboration, Department of Social Medicine, University of
Bristol, Bristol BS8 2PR, c Department of Clinical Oncology, Christie Hospital NHS Trust,
Manchester
Correspondence to: A Renehan
arenehan{at}picr.man.ac.uk
Objective:
To review the evidence from clinical
trials of follow up of patients after curative resection for colorectal cancer.
What is already known on this topic
Guidelines are inconclusive and clinical practice varies widely What this study adds
If computed tomography and frequent measurements of serum
carcinoembryonic antigen are used during follow up mortality related to
cancer is reduced by 9-13% This survival benefit is partly attributable to the earlier detection
of all recurrences, particularly the increased detection of isolated
recurrent disease
Design:
Systematic review and meta-analysis of
randomised controlled trials of intensive compared with control follow up.
Main outcome measures:
All cause mortality at five
years (primary outcome). Rates of recurrence of intraluminal, local,
and metastatic disease and metachronous (second colorectal primary)
cancers (secondary outcomes).
Results:
Five trials, which included 1342 patients, met the inclusion criteria. Intensive follow up was associated with a
reduction in all cause mortality (combined risk ratio 0.81, 95%
confidence interval 0.70 to 0.94, P=0.007). The effect was most
pronounced in the four extramural detection trials that used computed
tomography and frequent measurements of serum carcinoembryonic antigen
(risk ratio 0.73, 0.60 to 0.89, P=0.002). Intensive follow up was
associated with significantly earlier detection of all recurrences
(difference in means 8.5 months, 7.6 to 9.4 months, P<0.001) and
an increased detection rate for isolated local recurrences (risk ratio
1.61, 1.12 to 2.32, P=0.011).
Conclusions:
Intensive follow up after curative
resection for colorectal cancer improves survival. Large trials are
required to identify which components of intensive follow up are most beneficial.
There is a lack of direct evidence that intensive follow up after
initial curative treatment for colorectal cancer leads to increased
survival
The cumulative analysis of available data supports the view that
intensive follow up after curative resection for colorectal cancer
improves survival
Read all Rapid Responses